AM-679(FLAP 억제제)

AM-679 (FLAP inhibitor)
이 기사는 PLAP 억제제에 관한 것이다.카나비노이드 작용제에 대해서는 AM-679(카나비노이드)를 참조한다.
AM-679(FLAP 억제제)
AM-679 FLAP inhibitor.png
식별자
  • 3-(5-[(S)-1-acetyl-2,3-dihydro-1H-indol-2-ylmethoxy]-3-t-butylsulfanyl-1-[4-(5-methoxypyrimidin-2-yl)benzyl]-1H-indol-2-yl)-2,2-dimethylpropionic acid
CAS 번호
펍켐 CID
켐스파이더
유니
화학 및 물리적 데이터
공식C40H44N4O5S
어금질량692.88 g·1998−1
3D 모델(JSmol)
  • n5cc(OC)cnc5-c6cc(cc6)Cn(c1CC(C)C(=O)O)c4cc(cc4c1SC(C)C(C)C)OC3cc2ccc2N3C(=O)C(=O)C.
  • InChI=1S/C39H42N4O5S/c1-24(44)43-28(18-27-10-8-9-11-32(27)43)23-48-29-16-17-33-31(19-29)34(49-38(2,3)4)35(39(5,6)37(45)46)42(33)22-25-12-14-26(15-13-25)36-40-20-30(47-7)21-41-36/h8-17,19-21,28H,18,22-23H2,1-7H3,(H,45,46)/t28-/m0/s1 checkY
  • 키:XTSOSRWDZSKOSB-NDEPHWFRSA-N checkY
(iii)

AM-679는 5-Lipoxygenase 활성 단백질(FLAP)의 선택적 억제제 역할을 하는 약물이다.이 단백질은 염증에 관여하는 시스틸비닐 백혈구아렌의 생산에 관여하고 있으며, AM-679는 동물 연구에서 항염증 효과가 있다.[1][2]

참조

  1. ^ Stock N, Baccei C, Bain G, Broadhead A, Chapman C, Darlington J, King C, Lee C, Li Y, Lorrain DS, Prodanovich P, Rong H, Santini A, Zunic J, Evans JF, Hutchinson JH, Prasit P (January 2010). "5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—a potent FLAP inhibitor". Bioorganic & Medicinal Chemistry Letters. 20 (1): 213–7. doi:10.1016/j.bmcl.2009.10.131. PMID 19914828.
  2. ^ Musiyenko, A.; Correa, L.; Stock, N.; Hutchinson, J. H.; Lorrain, D. S.; Bain, G.; Evans, J. F.; Barik, S. (2009). "A Novel 5-Lipoxygenase-Activating Protein Inhibitor, AM679, Reduces Inflammation in the Respiratory Syncytial Virus-Infected Mouse Eye". Clinical and Vaccine Immunology. 16 (11): 1654–9. doi:10.1128/CVI.00220-09. PMC 2772391. PMID 19759251.